Cumulative Recurrence Rate and Risk Factors for Recurrent Abdominal Wall Endometriosis after Surgical Treatment in a Single Institution

• DOI: 10.3349/ymj.2022.63.5.446
• Publication Date: 2022-04-27T07:45:24Z
• Authors: Su Jin Kim; Su Hyeon Choi; Seyeon Won; Sohyun Shim; Nara Lee; Miseon Kim; Mi Kyoung Kim; Seok Ju Seong; Mi-La Kim
• Keywords: Cumulative risk; Lower abdominal pain

This study aimed to evaluate the cumulative recurrence rate and risk factors for recurrent abdominal wall endometriosis (AWE) after surgical treatment.A retrospective cohort was conducted at a single gynecological surgery center between January 2004 December 2020. Patients who were surgically treated followed up least 6 months selected.Eighteen patients with pathologically diagnosed AWE included in this study. The median follow-up duration 22.5 (range, 6-106). age 37 years 22-48), 33.3% of nulliparous. Among our study, 55.6% complained mass cyclic pain, 27.8% had palpable mass. In addition, 22.2% experienced 17.5±9.7 mean time recurrence. rates 24 60 treatment 23.8% 39.1%, respectively. There no statistically significant AWE, including postoperative medical treatment.The appears be correlated duration. factor AWE. Unlike ovarian endometriosis, hormonal does not seem lower findings current may help healthcare providers counselling managing